Libby Jones is the Program Director of Global Health Advocacy Incubator, GHAI’s Overdose Prevention Initiative. Libby leads the Initiative’s advocacy efforts, advancing federal policies to reduce the overdose death rate in the United States by expanding access to treatment and promoting harm reduction. Prior to joining GHAI, Libby served as government relations officer at the Pew Charitable Trusts’ substance use prevention and treatment initiative. Libby also has more than 15 years of experience working in the U.S. federal government, having held various positions in the U.S. Food and Drug Administration, Department of Commerce, Department of Justice.
Libby holds a Masters Degree in Human Rights from the London School of Economics and Political Science, and received a Bachelor of Arts degree from the College of William and Mary.
Rachel L. Levine, M.D. Admiral, U.S. Public Health Service Assistant Secretary for Health U.S. Department of Health and Human Services Admiral Rachel L. Levine...
What is scomiting? Dr. Jeff LaPoint explains scomiting, also known as cannabis hyperemesis syndrome. LaPoint is an emergency physician and toxicologist. He practices at...
A recent publication in JAMA Pediatrics shows that mental health burdens are associated with prenatal cannabis exposure that persists from childhood to early adolescence....